Eisai and Biogen's Leqembi won a coveted standard approval nod from the US Food and Drug Administration, the first Alzheimer's treatment to achieve that goal, clearing the way for wider insurance coverage of the drug.
Read the story here: https://reut.rs/46B1vLz
#News #Reuters #newsfeed #healthcare #alzheimer
Subscribe: http://smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Read the story here: https://reut.rs/46B1vLz
#News #Reuters #newsfeed #healthcare #alzheimer
Subscribe: http://smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Sign in or sign up to post comments.
Be the first to comment